Virtual Screening and Biological Evaluation of T22306 As a Potent Third-generation EGFR Inhibitor for NSCLC Treatment.
Anti-cancer agents in medicinal chemistry（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined